251 related articles for article (PubMed ID: 28757310)
21. The influence of study design and sex-differences on results from developmental neurotoxicity studies of bisphenol A: implications for toxicity testing.
Beronius A; Johansson N; Rudén C; Hanberg A
Toxicology; 2013 Sep; 311(1-2):13-26. PubMed ID: 23485653
[TBL] [Abstract][Full Text] [Related]
22. Meeting report: alternatives for developmental neurotoxicity testing.
Lein P; Locke P; Goldberg A
Environ Health Perspect; 2007 May; 115(5):764-8. PubMed ID: 17520065
[TBL] [Abstract][Full Text] [Related]
23. Developmental neurotoxicity test guidelines: problems and perspectives.
Tohyama C
J Toxicol Sci; 2016; 41(Spec):SP69-SP79. PubMed ID: 28250285
[TBL] [Abstract][Full Text] [Related]
24. Current status of developmental neurotoxicity: an industry perspective.
Kaufmann W
Toxicol Lett; 2003 Apr; 140-141():161-9. PubMed ID: 12676463
[TBL] [Abstract][Full Text] [Related]
25. A perspective on In vitro developmental neurotoxicity test assay results: An expert panel review.
Juberg DR; Fox DA; Forcelli PA; Kacew S; Lipscomb JC; Saghir SA; Sherwin CM; Koenig CM; Hays SM; Kirman CR
Regul Toxicol Pharmacol; 2023 Sep; 143():105444. PubMed ID: 37442267
[TBL] [Abstract][Full Text] [Related]
26. Behavioral toxicology in the 21st century: challenges and opportunities for behavioral scientists. Summary of a symposium presented at the annual meeting of the neurobehavioral teratology society, June, 2009.
Bushnell PJ; Kavlock RJ; Crofton KM; Weiss B; Rice DC
Neurotoxicol Teratol; 2010; 32(3):313-28. PubMed ID: 20171276
[TBL] [Abstract][Full Text] [Related]
27. International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes.
Bal-Price A; Crofton KM; Leist M; Allen S; Arand M; Buetler T; Delrue N; FitzGerald RE; Hartung T; Heinonen T; Hogberg H; Bennekou SH; Lichtensteiger W; Oggier D; Paparella M; Axelstad M; Piersma A; Rached E; Schilter B; Schmuck G; Stoppini L; Tongiorgi E; Tiramani M; Monnet-Tschudi F; Wilks MF; Ylikomi T; Fritsche E
Arch Toxicol; 2015 Feb; 89(2):269-87. PubMed ID: 25618548
[TBL] [Abstract][Full Text] [Related]
28. Introduction to the ILSI Research Foundation/Risk Science Institute reports from the expert working group on neurodevelopmental endpoints.
Fitzpatrick J; Mendez E; Walls I
Neurotoxicol Teratol; 2008; 30(4):263-5. PubMed ID: 18407461
[TBL] [Abstract][Full Text] [Related]
29. An analysis of the limitations and uncertainties of in vivo developmental neurotoxicity testing and assessment to identify the potential for alternative approaches.
Paparella M; Bennekou SH; Bal-Price A
Reprod Toxicol; 2020 Sep; 96():327-336. PubMed ID: 32781019
[TBL] [Abstract][Full Text] [Related]
30. Chemical testing strategies for predicting health hazards to children.
Lamb JC; Brown SM
Reprod Toxicol; 2000; 14(2):83-94. PubMed ID: 10825671
[TBL] [Abstract][Full Text] [Related]
31. International Regulatory Guiding Documents and Best Practice Recommendations on Peripheral Nervous System (PNS) Histopathologic Evaluation in Good Laboratory Practice (GLP)-Compliant Animal Toxicity Studies.
Bolon B; Bradley A; Butt MT; Jensen K; Rao DB
Toxicol Pathol; 2020 Jan; 48(1):78-86. PubMed ID: 31345129
[TBL] [Abstract][Full Text] [Related]
32. Developmental neurotoxicity testing: a path forward.
Crofton KM; Mundy WR; Shafer TJ
Congenit Anom (Kyoto); 2012 Sep; 52(3):140-6. PubMed ID: 22925214
[TBL] [Abstract][Full Text] [Related]
33. Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods.
Bal-Price A; Pistollato F; Sachana M; Bopp SK; Munn S; Worth A
Toxicol Appl Pharmacol; 2018 Sep; 354():7-18. PubMed ID: 29476865
[TBL] [Abstract][Full Text] [Related]
34. Comments from the Behavioral Teratology Committee of the Japanese Teratology Society on OECD guideline for the testing of chemicals, proposal for a new guideline 426, developmental neurotoxicity study, draft document (September 2003).
Fukui Y; Ema M; Fujiwara M; Higuchi H; Inouye M; Iwase T; Kihara T; Nishimura T; Oi A; Ooshima Y; Otani H; Shinomiya M; Sugioka K; Yamano T; Yamashita KH; Tanimura T;
Congenit Anom (Kyoto); 2004 Sep; 44(3):172-7. PubMed ID: 15327486
[TBL] [Abstract][Full Text] [Related]
35. Screening for Developmental Neurotoxicity at the National Toxicology Program: The Future Is Here.
Behl M; Ryan K; Hsieh JH; Parham F; Shapiro AJ; Collins BJ; Sipes NS; Birnbaum LS; Bucher JR; Foster PMD; Walker NJ; Paules RS; Tice RR
Toxicol Sci; 2019 Jan; 167(1):6-14. PubMed ID: 30496580
[TBL] [Abstract][Full Text] [Related]
36. A 'best practices' approach to neuropathologic assessment in developmental neurotoxicity testing--for today.
Bolon B; Garman R; Jensen K; Krinke G; Stuart B;
Toxicol Pathol; 2006; 34(3):296-313. PubMed ID: 16698729
[TBL] [Abstract][Full Text] [Related]
37. Zebrafish and nematodes as whole organism models to measure developmental neurotoxicity.
Hughes S; Hessel EVS
Crit Rev Toxicol; 2024 May; 54(5):330-343. PubMed ID: 38832580
[TBL] [Abstract][Full Text] [Related]
38. In vitro developmental neurotoxicity (DNT) testing: relevant models and endpoints.
Bal-Price AK; Hogberg HT; Buzanska L; Lenas P; van Vliet E; Hartung T
Neurotoxicology; 2010 Sep; 31(5):545-54. PubMed ID: 19969020
[TBL] [Abstract][Full Text] [Related]
39. Current assessment of the effects of environmental chemicals on the mammary gland in guideline rodent studies by the U.S. Environmental Protection Agency (U.S. EPA), Organisation for Economic Co-operation and Development (OECD), and National Toxicology Program (NTP).
Makris SL
Environ Health Perspect; 2011 Aug; 119(8):1047-52. PubMed ID: 21118785
[TBL] [Abstract][Full Text] [Related]
40. Identification of neurotoxicology (NT)/developmental neurotoxicology (DNT) adverse outcome pathways and key event linkages with in vitro DNT screening assays.
Pitzer EM; Shafer TJ; Herr DW
Neurotoxicology; 2023 Dec; 99():184-194. PubMed ID: 37866692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
